Our experience shows that patients find the weekly schedule incredibly manageable
Retatrutide is a next-generation metabolic medication still undergoing clinical evaluation
Hundreds of millions of people are taking or will soon take GLP-1 medications for the treatment of obesity and diabetes, Aparna Kamat, MD, director of the Division of Gynecologic Oncology at Houston Methodist Hospital, told Medical News Today
Analysis of the effects of GLP-1 and GLP-1RAs on cognitive, psychometric, cellular, and molecular changes in preclinical and clinical studies shows that these compounds and drugs modulate the molecular and cellular changes that determine the phenomenology of many brain diseases
The regulatory landscape may evolve
Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain